RX-108-A

N/A

Report date: 2026/02/25 20:02:36
NME

Base Information

Drug NameRX-108-A
Drug Alias NameRX108-ARX-108-A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium/potassium-transporting ATPase inhibitors
TargetsSodium/potassium-transporting ATPase
Therapy Area/IndicationsSolid tumoursColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesSuzhou Neupharma Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesSuzhou Neupharma Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A